Related Experiment Videos
Double-blind, randomized, controlled clinical trial of norfloxacin for cholera
S K Bhattacharya1, M K Bhattacharya, P Dutta
1National Institute of Cholera and Enteric Diseases (ICMR), Beliaghata, Calcutta, India.
Antimicrobial Agents and Chemotherapy
|May 1, 1990
Abstract:
In a double-blind, randomized clinical trial with 78 adults with acute watery diarrhea and severe dehydration, 37 subjects were positive for Vibrio cholerae. In conjunction with rehydration therapy, 13 patients received norfloxacin, 12 received trimethoprim-sulfamethoxazole (TMP-SMX), and 12 received a placebo. Norfloxacin was superior to TMP-SMX and to the placebo in reducing stool output, duration of diarrhea, fluid requirements, and vibrio excretion. TMP-SMX was no better than the placebo.